Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $551,053 - $2.01 Million
126,679 New
126,679 $1.43 Million
Q4 2021

Feb 14, 2022

SELL
$5.89 - $9.73 $168,571 - $278,472
-28,620 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$6.78 - $9.89 $232,899 - $339,731
-34,351 Reduced 54.55%
28,620 $244,000
Q2 2021

Aug 16, 2021

BUY
$7.24 - $11.2 $455,910 - $705,275
62,971 New
62,971 $508,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.